The role of soluble B cell maturation antigen as a biomarker in multiple myeloma

Taylor and Francis Group, Leukemia & Lymphoma, 2(64), p. 261-272, 2022

Journal article published in 2022 by Mohammed Alomari

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by